FindTrial
Sign In

Phase III study of SUN11031 for eating disorders

Phase III study of SUN11031 for eating disorders

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220697
Enrollment
Unknown
Registered
2009-03-19
Start date
2009-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating disorders (anorexia nervosa and eating disorders not otherwise specified)

Interventions

investigational material(s) Generic name etc : SUN11031 INN of investigational material : Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for I

Sponsors

DAIICHISANKYO Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of anorexia nervosa (restricting type) or eating disorders not otherwise specified according to the DSM-IV diagnostic criteria.

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026